Pricing Log in Create free account

Minerva Neurosciences, Inc (NERV) vs Seer, Inc. (SEER)

Minerva Neurosciences, Inc and Seer, Inc. are both Biotechnology companies. Minerva Neurosciences, Inc and Seer, Inc. are of similar size ($115.6M and $113.0M). Minerva Neurosciences, Inc has the higher net margin (0.00% vs −478.1%) and the higher return on invested capital (0.00% vs −60.8%). Across the 12 metrics below, Minerva Neurosciences, Inc leads on 7 and Seer, Inc. on 5.

Valuation

Metric NERV SEER Biotechnology median
P/E n/m n/m 8.50
P/S n/m 7.88 9.71
P/B n/m 0.50 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m 0.64 0.64
EV/Sales n/m (2.87) 9.21
Earnings yield (1,207.23%) (60.10%) (33.15%)
Free cash flow yield (24.00%) (39.27%) (25.50%)

Profitability

Metric NERV SEER Biotechnology median
Gross margin 0.00% 47.70% 65.16%
Operating margin 0.00% (498.19%) 0.00%
Net margin 0.00% (478.05%) 0.00%
Free cash flow margin 0.00% (309.34%) 0.00%
Return on equity 322.05% (26.45%) (56.36%)
Return on assets (629.71%) (23.47%) (48.04%)
Return on invested capital 0.00% (60.78%) 0.00%

Growth

Metric NERV SEER Biotechnology median
Revenue growth (TTM) — (12.71%) 6.02%
EPS growth (last fiscal year) (18,347.37%) 7.91% 30.26%
Revenue growth, 5-year CAGR — 90.78% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NERV SEER Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 20.14 14.74 4.72
Net debt to EBITDA 5.46 2.63 0.96

Dividend

Metric NERV SEER Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NERV SEER Biotechnology median
Market cap 115.55m 112.96m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack